Cell and animal NASH models validated our findings that c-MYC and SMAD2/3 were upregulated in HSCs, while THBS1 and p-STAT3 were upregulated in hepatocytes. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatohepatitis.